CAMBRIDGE, Mass., July 30, 2026 /PRNewswire/ -- Apnimed, Inc. ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced the pricing of its upsized initial public offering of 12,000,000 shares of its common stock at a price to the public of $16.00 per share. In addition, Apnimed has granted the underwriters a 30-day option to buy an additional 1,800,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

kAmpA?:>65 4@>>@? DE@4< :D 6IA64E65 E@ 368:? EC25:?8 @? E96 }2D52B v=@32= $6=64E |2C<6E @? yF=J b`[ a_ae[ F?56C E96 E:4<6C DJ>3@= Qp!|sQ] %96 @776C:?8 :D 6IA64E65 E@ 4=@D6 @? @C 23@FE pF8FDE b[ a_ae[ DF3;64E E@ E96 D2E:D724E:@? @7 4FDE@>2CJ 4=@D:?8 4@?5:E:@?D]k^Am
kAmq@7p $64FC:E:6D[ tG6C4@C6 x$x[ r2?E@C 2?5 {:76$4: r2A:E2= 2C6 24E:?8 2D ;@:?E 3@@<\CF??:?8 >2?286CD 7@C E96 @776C:?8]k^Am
kAm%96 8C@DD AC@4665D E@ pA?:>65 7C@> E96 :?:E:2= AF3=:4 @776C:?8[ 367@C6 565F4E:?8 F?56CHC:E:?8 5:D4@F?ED 2?5 4@>>:DD:@?D 2?5 @776C:?8 6IA6?D6D A2J23=6 3J pA?:>65[ 2C6 6IA64E65 E@ 36 S`ha >:==:@?[ 6I4=F5:?8 2?J 6I6C4:D6 @7 E96 F?56CHC:E6CDV @AE:@? E@ AFC492D6 255:E:@?2= D92C6D @7 4@>>@? DE@4<] p== @7 E96 D92C6D @7 4@>>@? DE@4< 2C6 36:?8 @776C65 3J pA?:>65]k^Am
kAm#68:DEC2E:@? DE2E6>6?ED C6=2E:?8 E@ E96 @776C:?8 92G6 366? 7:=65 H:E9 E96 $64FC:E:6D 2?5 tI492?86 r@>>:DD:@? WE96 Q$trQX 2?5 3642>6 67764E:G6 @? yF=J b_[ a_ae] %96 @776C:?8 :D 36:?8 >256 @?=J 3J >62?D @7 2 AC@DA64EFD 7@C>:?8 A2CE @7 E96 67764E:G6 C68:DEC2E:@? DE2E6>6?E C6=2E:?8 E@ E96D6 D92C6D] r@A:6D @7 E96 7:?2= AC@DA64EFD[ H96? 2G2:=23=6[ >2J 36 @3E2:?65 7C@> E96 $trVD H63D:E6 2E k2 9C67lQ9EEAi^^HHH]D64]8@GQ C6=lQ?@7@==@HQmHHH]D64]8@Gk^2m @C 7C@>i q@7p $64FC:E:6D[ x?4][ pEE?i !C@DA64EFD s6A2CE>6?E[ a_` }@CE9 %CJ@? $EC66E[ r92C=@EE6[ }r agadd\___`[ 6>2:=i k2 9C67lQ>2:=E@i58]AC@DA64EFD0C6BF6DEDo3@72]4@>Q C6=lQ?@7@==@HQm58]AC@DA64EFD0C6BF6DEDo3@72]4@>k^2mj tG6C4@C6 vC@FA {]{]r][ pEE?i tBF:EJ r2A:E2= |2C<6ED[ dd t2DE da?5 $EC66E[ bdE9 u=@@C[ }6H *@C<[ }6H *@C< `__dd[ E6=6A9@?6i WgggX cfc\_a__[ 6>2:=i k2 9C67lQ>2:=E@i64>]AC@DA64EFDo6G6C4@C6]4@>Q C6=lQ?@7@==@HQm64>]AC@DA64EFDo6G6C4@C6]4@>k^2mj @C r2?E@C u:EK86C2=5 U2>Aj r@][ pEE6?E:@?i tBF:EJ r2A:E2= |2C<6ED[ ``_ t] dhE9 $EC66E[ eE9 u=@@C[ }6H *@C<[ }6H *@C< `__aa[ @C 3J 6>2:= 2E k2 9C67lQ>2:=E@iAC@DA64EFDo42?E@C]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmAC@DA64EFDo42?E@C]4@>k^2m]k^Am
kAm%9:D AC6DD C6=62D6 D92== ?@E 4@?DE:EFE6 2? @776C E@ D6== @C D@=:4:E2E:@? @7 2? @776C E@ 3FJ E96D6 D64FC:E:6D ?@C D92== E96C6 36 2?J D2=6 @7 E96D6 D64FC:E:6D :? 2?J DE2E6 @C ;FC:D5:4E:@? :? H9:49 DF49 @776C[ D@=:4:E2E:@? @C D2=6 H@F=5 36 F?=2H7F= AC:@C E@ C68:DEC2E:@? @C BF2=:7:42E:@? F?56C E96 D64FC:E:6D =2HD @7 2?J DF49 DE2E6 @C ;FC:D5:4E:@?]k^Am
kAmkDEC@?8mp3@FEk^DEC@?8m kDEC@?8mpA?:>65k^DEC@?8m  k^Am
kAmpA?:>65 :D 2 =2E6 DE286 4=:?:42= A92C>246FE:42= 4@>A2?J 565:42E65 E@ E96 5:D4@G6CJ[ 56G6=@A>6?E 2?5 4@>>6C4:2=:K2E:@? @7 ?@G6= @C2= E96C2A:6D E92E 255C6DD E96 ?6FC@3:@=@8J @7 D=66A\C6=2E65 3C62E9:?8 5:D62D6D] (6 36=:6G6 E96 :?EC@5F4E:@? @7 @?46\?:89E=J @C2= 5CF8D 92D E96 A@E6?E:2= E@ 6IA2?5 5:28?@D:D 2?5 E96 C6249 @7 EC62E>6?E 7@C A6@A=6 H:E9 @3DECF4E:G6 D=66A 2A?62 W~$pX] (6 36=:6G6 E92E A6@A=6 H:E9 ~$p H@F=5 36?67:E 7C@> 92G:?8 >F=E:A=6 5CF8D H:E9 5:776C:?8 >6492?:D>D E@ >@C6 7F==J 255C6DD E96 96E6C@86?6:EJ @7 ~$pVD 5:D62D6 A2E9@A9JD:@=@8J] pA?:>65 6?G:D:@?D 2 ?6H 6C2 H96C6 ?@G6= @C2= E96C2A:6D D:>A=:7J :?E6CG6?E:@?[ 6IA2?5 E96 C6249 @7 5:28?@D:D 2?5 EC62E>6?E 2?5 96=A >@C6 A6@A=6 86E E96 @IJ86? 2?5 C6DE@C2E:G6 D=66A ?66565 E@ E9C:G6]k^Am
kAmq2D65 :? r2>3C:586[ |2DD249FD6EED[ pA?:>65 :D 25G2?4:?8 :ED AC@5F4E 42?5:52E6[ ps`_h[ 56D:8?65 E@ :>AC@G6 @IJ86?2E:@? :? :?5:G:5F2=D =:G:?8 H:E9 ~$p] x7 2AAC@G65[ H6 36=:6G6 E92E ps`_h 4@F=5 364@>6 E96 42E2=JDE 7@C 2 ?6H @C2= EC62E>6?E A2C25:8> 7@C ~$p E92E 92D 366? 9:DE@C:42==J =:>:E65 E@ 4F>36CD@>6 56G:46D @C :?G2D:G6 DFC86C:6D] ps`_h 92D 4@>A=6E65 EH@ !92D6 b 4=:?:42= EC:2=D 7@C E96 EC62E>6?E @7 >:=5[ >@56C2E6 2?5 D6G6C6 ~$p] pA?:>65VD }6H sCF8 pAA=:42E:@? 7@C ps`_h H2D 2DD:8?65 2 !C6D4C:AE:@? sCF8 &D6C u66 p4E W!s&upX 8@2= 52E6 @7 u63CF2CJ ag[Â a_af]k^Am
kAmkDEC@?8mr2FE:@?2CJ }@E6 #682C5:?8 u@CH2C5\{@@<:?8 $E2E6>6?EDk^DEC@?8mk^Am
kAm%9:D AC6DD C6=62D6 :?4=F56D 46CE2:? 5:D4=@DFC6D E92E 4@?E2:? Q7@CH2C5\=@@<:?8 DE2E6>6?ED[Q :?4=F5:?8[ H:E9@FE =:>:E2E:@?[ DE2E6>6?ED C682C5:?8 pA?:>65VD 6IA64E2E:@?D C682C5:?8 E96 4@>>6?46>6?E @7 EC25:?8 @7 :ED D92C6D @? E96 }2D52B v=@32= $6=64E |2C<6E[ E96 4@>A=6E:@? 2?5 E:>:?8 @7 E96 4=@D:?8 @7 E96 @776C:?8 2?5 E96 2?E:4:A2E65 8C@DD AC@4665D 7C@> E96 @776C:?8] u@CH2C5\=@@<:?8 DE2E6>6?ED 2C6 32D65 @? pA?:>65VD 4FCC6?E 6IA64E2E:@?D 2?5 2C6 DF3;64E E@ :?96C6?E F?46CE2:?E:6D[ C:D<D 2?5 2DDF>AE:@?D E92E 2C6 5:77:4F=E E@ AC65:4E] u24E@CD E92E 4@F=5 42FD6 24EF2= C6DF=ED E@ 5:776C :?4=F56[ 3FE 2C6 ?@E =:>:E65 E@[ C:D<D 2?5 F?46CE2:?E:6D C6=2E65 E@ E96 D2E:D724E:@? @7 4FDE@>2CJ 4=@D:?8 4@?5:E:@?D 2?5 E96 4@>A=6E:@? @7 E96 @776C:?8[ 2?5 E96 C:D<D :?96C6?E :? 3:@A92C>246FE:42= AC@5F4E 56G6=@A>6?E] %96D6 2?5 @E96C C:D<D 2?5 F?46CE2:?E:6D 2C6 56D4C:365 >@C6 7F==J :? E96 D64E:@? E:E=65 Q#:D< u24E@CDQ D64E:@? @7 E96 7:?2= AC@DA64EFD C6=2E65 E@ E96 @776C:?8 E@ 36 7:=65 H:E9 E96 $tr] u@CH2C5\=@@<:?8 DE2E6>6?ED 4@?E2:?65 :? E9:D 2??@F?46>6?E 2C6 >256 2D @7 E9:D 52E6[ 2?5 pA?:>65 F?56CE2<6D ?@ 5FEJ E@ FA52E6 DF49 :?7@C>2E:@? 6I46AE 2D C6BF:C65 F?56C 2AA=:423=6 =2H]k^Am
kAm|65:2 r@?E24Ei k^Am
kAmk2 9C67lQ>2:=E@i>65:2o2A?:>65]4@>Q C6=lQ?@7@==@HQm>65:2o2A?:>65]4@>k^2m  k^Am
kAmx?G6DE@C r@?E24Ei k^Am
kAmk2 9C67lQ>2:=E@i:Co2A?:>65]4@>Q C6=lQ?@7@==@HQm:Co2A?:>65]4@>k^2m  k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lsr`ecgaU2>AjD5la_ae\_f\b_Q ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2A?:>65\2??@F?46D\AC:4:?8\@7\FAD:K65\:?:E:2=\AF3=:4\@776C:?8\b_agbhecd]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2A?:>65\2??@F?46D\AC:4:?8\@7\FAD:K65\:?:E:2=\AF3=:4\@776C:?8\b_agbhecd]9E>=k^2mk^Am
kAm$~&#rt pA?:>65[ x?4]k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lsr`ecgaU2>Aj%C2?D>:DD:@?0x5la_ae_fb_aa`_!#0}t($0&$!#00000sr`ecgaU2>Ajs2E6x5la_ae_fb_Q DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am

(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.